Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.
Radius Health Dividend Announcement
• Radius Health announced a quarterly dividend of $0.19 per ordinary share which will be made payable on 2024-11-26. Ex dividend date: 2024-11-12
• Radius Health annual dividend for 2024 was $0.75
• Radius Health annual dividend for 2023 was $0.56
• Radius Health's trailing twelve-month (TTM) dividend yield is 4.42%
• Radius Health's payout ratio for the trailing twelve months (TTM) is -52.99%
Radius Health Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-12 | $0.19 | quarterly | 2024-11-26 |
2024-07-22 | $0.19 | quarterly | 2024-08-05 |
2024-04-19 | $0.19 | quarterly | 2024-05-06 |
2024-02-02 | $0.19 | quarterly | 2024-02-20 |
2023-11-10 | $0.19 | quarterly | 2023-11-27 |
2023-07-14 | $0.19 | quarterly | 2023-07-31 |
2023-04-21 | $0.19 | quarterly | 2023-05-08 |
Radius Health Dividend per year
Radius Health Dividend Yield
Radius Health current trailing twelve-month (TTM) dividend yield is 4.42%. Interested in purchasing Radius Health stock? Use our calculator to estimate your expected dividend yield:
Radius Health Financial Ratios
Radius Health Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Radius Health stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.